Jun 10, 2015
VacciXcell officially launched on 3 June, 2015 at World Vaccine Congress Asia held at Suntec Convention and Exhibition Centre in Singapore! We are excited to embark on this journey with you, offering turnkey solutions to clients of all applications and budgets.
Thanks to the hard work of our dedicated team of bioprocessing specialists and engineers, we now provide End to End technologies and services. From upstream bioprocessing and downstream bioprocessing to formulation and filling, VacciXcell has a complete biopharmaceutical platform.
In conjunction with the VacciXcell launch, Mr. XL Lin, founder of VacciXcell, gave a talk on the innovative tide-motion-based bioreactors, TideCell and BelloStage, producing higher yields at lower cost for sustainable vaccine production. It is a mission of ours to make human and animal immunization available and accessible to all developing nations by introducing and adopting a self-sufficient system. We demonstrated the units at the exhibition. The feedback we received was incredibly positive and enthusiastic!
We wish to bring about change and make a difference in this world by advancing the biopharmaceutical industry through application of science and engineering with our quality management and manufacturing experience, and we hope you will join this ride with us!
Please do not hesitate to contact us for more information.